Biotechnology, Health Care, Life Science, Neuroscience, Therapeutics
BrainChild Bio
BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.
Series A · $116M · 28d agobrainchildbio.com
Hiring velocity
- Open roles
- 4
- Added, 30 days
- +0
- Added, 7 days
- +0
- Closed, 30 days
- 0
- Raised
- 28 days ago
- Led by
- WRF Capital, Seattle Children’s, ScaleReady
- Team size
- 11-50
- HQ
- Seattle, Washington, United States
- Newest role
- 1mo ago
- Tracked since
- Oct 4, 2026
Where they're hiring
Legal1
Hardware1
Operations1
Engineering1
Open roles at BrainChild Bio
+ 4 roles posted in the last 48 hours, visible to members →Source: brainchildbio.com, checked daily.